Neuropsychiatric symptoms are associated with exacerbated cognitive impairment in covert cerebral small vessel disease
Authors:
Open Access
- 30 August 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 29 (5) , 431-438
Abstract
Objectives: Neuropsychiatric symptoms are related to disease progression and cognitive decline over time in cerebral small vessel disease (SVD) but their significance is poorly understood in covert SVD. We investigated neuropsychiatric symptoms and their relationships between cognitive and functional abilities in subjects with varying degrees of white matter hyperintensities (WMH), but without clinical diagnosis of stroke, dementia or significant disability.Methods: The Helsinki Small Vessel Disease Study consisted of 152 subjects, who underwent brain magnetic resonance imaging (MRI) and comprehensive neuropsychological evaluation of global cognition, processing speed, executive functions, and memory. Neuropsychiatric symptoms were evaluated with the Neuropsychiatric Inventory Questionnaire (NPI-Q,n= 134) and functional abilities with the Amsterdam Instrumental Activities of Daily Living questionnaire (A-IADL,n= 132), both filled in by a close informant.Results: NPI-Q total score correlated significantly with WMH volume (rs= 0.20,p= 0.019) and inversely with A-IADL score (rs = −0.41,p< 0.001). In total, 38% of the subjects had one or more informant-evaluated neuropsychiatric symptom. Linear regressions adjusted for age, sex, and education revealed no direct associations between neuropsychiatric symptoms and cognitive performance. However, there were significant synergistic interactions between neuropsychiatric symptoms and WMH volume on cognitive outcomes. Neuropsychiatric symptoms were also associated with A-IADL score irrespective of WMH volume.Conclusions: Neuropsychiatric symptoms are associated with an accelerated relationship between WMH and cognitive impairment. Furthermore, the presence of neuropsychiatric symptoms is related to worse functional abilities. Neuropsychiatric symptoms should be routinely assessed in covert SVD as they are related to worse cognitive and functional outcomes.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- The vascular depression hypothesis: mechanisms linking vascular disease with depressionMolecular Psychiatry, 2013
- Neuropsychiatric Symptoms and the Risk of Institutionalization and Death: The Aging, Demographics, and Memory StudyJournal of the American Geriatrics Society, 2011
- Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Normal Cognitive AgingArchives of General Psychiatry, 2008
- Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2007
- Cerebral small-vessel disease and decline in information processing speed, executive function and memoryBrain, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and MethodologyNeuroepidemiology, 2004
- The Neuropsychiatric InventoryNeurology, 1994
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988